BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34088274)

  • 1. Chronotherapy for morning blood pressure surge in hypertensive patients: a systematic review and meta-analysis.
    Xie Z; Zhang J; Wang C; Yan X
    BMC Cardiovasc Disord; 2021 Jun; 21(1):274. PubMed ID: 34088274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evening versus morning dosing regimen drug therapy for hypertension.
    Zhao P; Xu P; Wan C; Wang Z
    Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD004184. PubMed ID: 21975743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evening -versus morning- dosing drug therapy for chronic kidney disease patients with hypertension: a systematic review.
    Liu X; Liu X; Huang W; Leo S; Li Y; Liu M; Yuan H
    Kidney Blood Press Res; 2014; 39(5):427-40. PubMed ID: 25471279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis.
    Wang C; Ye Y; Liu C; Zhou Y; Lv L; Cheng C; Li S; Lou T; Liu X
    Intern Med J; 2017 Aug; 47(8):900-906. PubMed ID: 28544243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.
    Izquierdo-Palomares JM; Fernandez-Tabera JM; Plana MN; Añino Alba A; Gómez Álvarez P; Fernandez-Esteban I; Saiz LC; Martin-Carrillo P; Pinar López Ó
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009462. PubMed ID: 27888640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of home blood pressure measured in morning and evening: evaluation in normotensives and hypertensives in Japanese urban population.
    Kawabe H; Saito I; Saruta T
    Hypertens Res; 2005 Jun; 28(6):491-8. PubMed ID: 16231754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hypertensive efficacy of amlodipine dosing during morning versus evening: A meta-analysis.
    Luo Y; Ren L; Jiang M; Chu Y
    Rev Cardiovasc Med; 2019 Jun; 20(2):91-98. PubMed ID: 31345001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
    Hermida RC
    Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of Antihypertensive Drug Therapy: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Maqsood MH; Messerli FH; Skolnick AH; Newman JD; Berger JS; Bangalore S
    Hypertension; 2023 Jul; 80(7):1544-1554. PubMed ID: 37212152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypertension with chronotherapy: is it time of drug administration?
    Stranges PM; Drew AM; Rafferty P; Shuster JE; Brooks AD
    Ann Pharmacother; 2015 Mar; 49(3):323-34. PubMed ID: 25515866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study.
    Portaluppi F; Smolensky MH
    Chronobiol Int; 2010 Sep; 27(8):1652-67. PubMed ID: 20854140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the morning blood pressure surge treated with olmesartan in Chinese patients with mild to moderate essential hypertension--a multicenter, open-label, single treatment group clinical study.
    Jiao Y; Ke Y; Sun N; Wang J; Deng W; Zhu J; ;
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):653-9. PubMed ID: 22774407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotherapy for hypertension in patients with chronic kidney disease: a systematic review and meta-analysis in non-black patients.
    Wang C; Qiu X; Lv L; Huang J; Li S; Lou T; Liu X
    Int Urol Nephrol; 2017 Apr; 49(4):651-659. PubMed ID: 27844408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications.
    Hermida RC; Smolensky MH; Balan H; Castriotta RJ; Crespo JJ; Dagan Y; El-Toukhy S; Fernández JR; FitzGerald GA; Fujimura A; Geng YJ; Hermida-Ayala RG; Machado AP; Menna-Barreto L; Mojón A; Otero A; Rudic RD; Schernhammer E; Skarke C; Steen TY; Young ME; Zhao X
    Chronobiol Int; 2021 Jan; 38(1):1-26. PubMed ID: 33342316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial blood pressure circadian rhythm: significance and clinical implications].
    Gonzalez Rodriguez E; Hernandez A; Dibner C; Koehler Ballan B; Pechère-Bertschi A
    Rev Med Suisse; 2012 Sep; 8(353):1709-12, 1714-5. PubMed ID: 23029984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronotherapy on blood pressure control in non-dipper patients with refractory hypertension.
    Almirall J; Comas L; Martínez-Ocaña JC; Roca S; Arnau A
    Nephrol Dial Transplant; 2012 May; 27(5):1855-9. PubMed ID: 21940489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evening versus morning polypill utilization study: the TEMPUS rationale and design.
    Lafeber M; Grobbee DE; Bots ML; Thom S; Webster R; Rodgers A; Visseren FL; Spiering W
    Eur J Prev Cardiol; 2014 Apr; 21(4):425-33. PubMed ID: 23382539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.